REPL — Replimune Group, Inc. stock price, charts and financials

QT91Replimune Group, Inc.

Replimune Group, Inc. (NASDAQ: REPL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.92
+0.01+0.08%
OverviewShort InterestFilings
REPLQT91Replimune Group, Inc.·NASDAQ
11.92+0.08%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 29, 2026EFFECTNotice of effectiveness
Jul 29, 2026DEFA14AAdditional proxy soliciting materials
Jul 29, 2026ARSAnnual report to shareholders
Jul 29, 2026DEF 14ADefinitive proxy statement
Jul 24, 2026S-3/AShelf registration statement (amended)
Jul 13, 2026PRE 14APreliminary proxy statement
Jun 29, 202610-KAnnual report
Jun 29, 2026S-8Registration of employee benefit securities
Jun 29, 20268-KCurrent report
Jun 26, 20268-KCurrent report
Jun 03, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 21, 2026SC 13GBeneficial ownership statement (passive)
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 13, 20268-KCurrent report
#1 / 25 of 341
Page
▼
/ 14